PTPN12 is a tumor suppressor that inhibits multiple receptor tyrosine kinases, including epithelial growth factor receptor (EGFR) and HER2 in triple-negative breast cancer [41, 42]. Here, EGFR is linked to triple-negative breast carcinoma.